Healthcare Provider Leads Networking Transportation 
Clarify Health
OCTOBER 10, 2023
When building provider networks, it is crucial to include providers who can assess and address social determinants to ensure that care is equitable, patient-centered, and effective in improving health outcomes and reducing healthcare disparities. Cost Savings: Addressing SDoH can lead to cost savings in the long run.
Clarivate
APRIL 24, 2023
These developments, together with Walgreens’ recent rollout of Health Corners that help patients manage chronic conditions and its October 2022 announcement that it would fully acquire CareCentrix (a platform that coordinates post-acute and home care), underscore Walgreens’ plans to become a leading healthcare provider.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 24, 2023
Energy crisis effects will be felt across healthcare, but for medicines manufacturing and delivery the issue is especially complex because the networks of medicine supply extend across the globe and across countries which see differing impacts of energy costs and supply. Medicines manufacturing is energy intensive.
Impetus Digital
JANUARY 30, 2023
This could mean anything from developing policies that promote fairness and transparency in pricing to creating networks of distribution points that ensure medications can be delivered promptly wherever needed. This can also lead to decreased customer satisfaction and damage any business’s reputation. About the Author David L.
PM360
SEPTEMBER 7, 2023
The impact on caregiver health goes far beyond the physical, as the mental demands of caregiving often result in poor self-care, increased depression, psychological distress, and strained relationships, all of which can lead to caregiver burnout. Providing caregiver-targeted tools and resources to healthcare providers is a win-win.
Clarify Health
OCTOBER 26, 2021
The solution delivers instant access to precision insights on patient cohorts, healthcare providers, and market intelligence, which draw upon data from over 300M patient lives, including de-identified government and commercial claims, clinical, prescription and dispensing, and SDoH data at the patient-level. 2] Figure 1.
pharmaphorum
JANUARY 4, 2023
The supply chain for allogeneic cell therapies doesn’t start with the patient – donor cells are collected and then transported to the manufacturer for modification and filling and finishing, before being shipped to a GMP-compliant storage facility where products are kept frozen for on-demand delivery.
Expert insights. Personalized for you.
59 
Let's personalize your content